Research location
Port Richey
Florida, United States
Advertisement
Research activity in Port Richey
Florida, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 11 trials and 14 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Port Richey
11 linked trials · page 1 of 1Registry of Asthma Patients Initiating DUPIXENT®NCT04287621 · 2020-03-02 · 1 site observation
COMPLETED
Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid ArthritisNCT02831855 · 2016-09-01 · 2 site observations
COMPLETED
Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) TreatmentNCT02873936 · 2016-07-27 · 1 site observation
COMPLETED
A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background MethotrexateNCT02147587 · 2014-06-01 · 2 site observations
COMPLETED
A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or PlaceboNCT01359150 · 2011-09-01 · 1 site observation
COMPLETED
Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's DiseaseNCT01099332 · 2009-11-01 · 1 site observation
UNKNOWN
A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis MedicationsNCT00856544 · 2009-05-01 · 1 site observation
COMPLETED
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid ArthritisNCT00413699 · 2007-02-05 · 2 site observations
COMPLETED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 1 site observation
COMPLETED
A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid ArthritisNCT00424294 · 2006-06-01 · 1 site observation
TERMINATED
Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 WeeksNCT00147498 · 2005-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.